申请人:Layton Mark E.
公开号:US20090124600A1
公开(公告)日:2009-05-14
Compounds represented by Formula (I): and/or pharmaceutically acceptable salts, individual enantiomers and stereoisomers thereof, are effective as NMDA/NR2B antagonists useful for treating conditions such as pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke.
由公式(I)表示的化合物及/或其药学上可接受的盐、单一对映体和立体异构体,作为NMDA/NR2B拮抗剂,对于治疗疼痛、帕金森病、阿尔茨海默病、癫痫、抑郁症、焦虑症、缺血性脑损伤包括中风等疾病是有效的。